Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company’s Ongoing Commercialization and Broader Strategic Initiatives

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WDI), a venture backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, today announced the appointment of Tom Dunlap to the Board of Directors.

“We are pleased to have Tom Dunlap join our Board of Directors. Tom brings a wealth in ophthalmic industry leadership experience and will fit well with our existing team,” said WaveFront Dynamics’ Founder and CEO, Dan Neal, Ph.D. “Tom has extensive experience in the ophthalmic and broader medical industries at both large, well-established companies and innovative start-ups.”

Tom Dunlap is a senior executive with relevant expertise in commercialization and business strategy in many Ophthalmic medical device businesses. His proven track record includes experience in entrepreneurial ventures and multinational companies. He has held executive management positions at Mynosys Cellular Devices (Centricity Vision), HOYA Surgical Optics, Allergan Medical Optics (J&J Vision), Bausch + Lomb, American Hospital Supply Corporation, Surgilase, Inc. and Coherent, Inc. He brings experience as an Independent Board member, Non-Executive Director, and Chairman of the Board with private Ophthalmic medical device companies. Tom holds an MBA, with honors from the University of Southern California in Los Angeles, California, and a BA, with honors from Ashland University in Ashland, Ohio.

Mr. Dunlap commented on joining the company’s Board of Directors, “I am honored to be appointed to the Board of Directors and excited about WaveFront Dynamics’ future, especially the significant opportunity launching the WaveDȳn® Vision Analyzer in the United States. Dan has set the company on strong footing with an incredibly strong team, and a novel device which will expand treatment options by providing diagnostic data to enhance patients’ quality of vision. We are well positioned to continue to deliver for patients and the physicians who serve them, while increasing value for our shareholders.”


About WaveFront Dynamics Inc.

Founded in 2019, WaveFront Dynamics is a privately held, commercial-stage medical device company with innovative wavefront diagnostic technology for use in the vision care industry. The company is leveraging its WaveDȳn® Vision Analyzer with dynamic measurements to yield new insights into assessing visual performance, advancing treatment options, and improving quality of life for the visually impaired. For more information, please visit

WaveDȳn is a registered trademark of WaveFront Dynamics Inc.


Investor and Media Inquiries:
Dan Neal, Ph.D., Founder, CEO
+1 505.453.7918